These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 16023893)
1. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Lai CM; Shen WY; Brankov M; Lai YK; Barnett NL; Lee SY; Yeo IY; Mathur R; Ho JE; Pineda P; Barathi A; Ang CL; Constable IJ; Rakoczy EP Mol Ther; 2005 Oct; 12(4):659-68. PubMed ID: 16023893 [TBL] [Abstract][Full Text] [Related]
2. rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector. Lai CM; Estcourt MJ; Wikstrom M; Himbeck RP; Barnett NL; Brankov M; Tee LB; Dunlop SA; Degli-Esposti MA; Rakoczy EP Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4279-87. PubMed ID: 19357358 [TBL] [Abstract][Full Text] [Related]
3. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072 [TBL] [Abstract][Full Text] [Related]
4. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462 [TBL] [Abstract][Full Text] [Related]
5. Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates. Lai CM; Estcourt MJ; Himbeck RP; Lee SY; Yew-San Yeo I; Luu C; Loh BK; Lee MW; Barathi A; Villano J; Ang CL; van der Most RG; Constable IJ; Dismuke D; Samulski RJ; Degli-Esposti MA; Rakoczy EP Gene Ther; 2012 Oct; 19(10):999-1009. PubMed ID: 22071974 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Bainbridge JW; Mistry A; De Alwis M; Paleolog E; Baker A; Thrasher AJ; Ali RR Gene Ther; 2002 Mar; 9(5):320-6. PubMed ID: 11938451 [TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization. Min Z; Qiang W; Benwen S; Bin L; Xinhua D Curr Eye Res; 2009 May; 34(5):401-10. PubMed ID: 19401884 [TBL] [Abstract][Full Text] [Related]
8. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010 [TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor. Mahendra G; Kumar S; Isayeva T; Mahasreshti PJ; Curiel DT; Stockardt CR; Grizzle WE; Alapati V; Singh R; Siegal GP; Meleth S; Ponnazhagan S Cancer Gene Ther; 2005 Jan; 12(1):26-34. PubMed ID: 15359287 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization. El Sanharawi M; Touchard E; Benard R; Bigey P; Escriou V; Mehanna C; Naud MC; Berdugo M; Jeanny JC; Behar-Cohen F Gene Ther; 2013 Nov; 20(11):1093-103. PubMed ID: 23804076 [TBL] [Abstract][Full Text] [Related]
12. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147 [TBL] [Abstract][Full Text] [Related]
13. VEGF blockade decelerates the growth of a murine experimental osteosarcoma. Yin D; Jia T; Gong W; Yu H; Wooley PH; Mott MP; Yang SY Int J Oncol; 2008 Aug; 33(2):253-9. PubMed ID: 18636145 [TBL] [Abstract][Full Text] [Related]